In chemico evaluation of skin metabolism: Investigation of eugenol and isoeugenol by electrochemistry coupled to liquid chromatography and mass spectrometry

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 913-914, Issue , 2013, Pages 106-112

  Melles, Daniel ^a   Vielhaber, Torsten ^a   Baumann, Anne ^a   Zazzeroni, Raniero ^b   Karst, Uwe ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNILEVER RESEARCH   (United Kingdom)

Author keywords

Electrochemistry; Eugenol; Isoeugenol; Metabolism; Protein modification

Indexed keywords

ADDUCT FORMATION; ADVERSE EFFECT; ALTERNATIVE METHODS; ANIMAL STUDIES; ANIMAL TESTS; COSMETIC PRODUCTS; DEALKYLATION; EUGENOL; EUROPEAN COMMISSION; GLUTATHIONES; INSTRUMENTAL APPROACH; ISOEUGENOL; LACTOGLOBULIN; MECHANISM OF OXIDATION; MODEL SUBSTANCE; OXIDATION BEHAVIOURS; OXIDATION PRODUCTS; PROTEIN MODIFICATIONS; QUINOID SPECIES; REACTIVE INTERMEDIATE; SENSITIZATION PROCESS; SKIN METABOLISM; SKIN PROTEINS; SKIN SENSITIZATION;

ANIMALS; CHROMATOGRAPHY; ELECTROCHEMICAL OXIDATION; ELECTROCHEMISTRY; MASS SPECTROMETRY; METABOLISM; PHYSIOLOGY; PROTEINS;

HIGH PRESSURE LIQUID CHROMATOGRAPHY;

BETA LACTOGLOBULIN; EUGENOL; GLUTATHIONE; ISOEUGENOL;

ALKYLATION; ARTICLE; CLINICAL EVALUATION; DEALKYLATION; ELECTROCHEMISTRY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLISM; OXIDATION; PRIORITY JOURNAL; SKIN METABOLISM;

CHROMATOGRAPHY, LIQUID; ELECTROCHEMICAL TECHNIQUES; EUGENOL; GLUTATHIONE; LACTOGLOBULINS; MASS SPECTROMETRY; OXIDATION-REDUCTION;

ANIMALIA;

EID: 84872408405     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2012.12.004     Document Type: Article

References (36)

1. Basketter D.A., Andersen K.E., Liden C., Van Loveren H., Boman A., Kimber I., Alanko K., Berggren E. Contact Dermatitis 2005, 52:39.
2. Calnan C.D., Cronin E., Rycroft R.J. Contact Dermatitis 1980, 6:500.
3. Klecak G., Geleick H., Frey J. J. Soc. Cosmet. Chem. 1977, 28:53.
4. Larsen W.G. Arch. Dermatol. 1977, 113:623.
5. Alenius H., Roberts D.W., Tokura Y., Lauerma A., Patlewicz G., Roberts M.S. Drug Discov. Today: Dis. Mech. 2008, 5:e211.
6. Gober M.D., Gaspari A.A. Curr. Dir. Autoimmun. 2008, 10:1.
7. Kimber I., Basketter D.A., Gerberick G.F., Dearman R.J. Int. Immunopharmacol. 2002, 2:201.
8. Khan F.D., Roychowdhury S., Gaspari A.A., Svensson C.K. Expert Opin. Drug Metab. Toxicol. 2006, 2:261.
9. Divkovic M., Pease C.K., Gerberick G.F., Basketter D.A. Contact Dermatitis 2005, 53:189.
10. Basketter D.A., Dooms-Goossens A., Karlberg A.T., Lepoittevin J.P. Contact Dermatitis 1995, 32:65.
11. Aeby P., Sieber T., Beck H., Gerberick G.F., Goebel C.J. J. Invest. Dermatol. 2009, 129:99.
12. Kalgutkar A.S., Gardner I., Obach R.S., Shaffer C.L., Callegari E., Henne K.R., Mutlib A.E., Dalvie D.K., Lee J.S., Nakai Y., O'Donnell J.P., Boer J., Harriman S.P. Curr. Drug Metab. 2005, 6:161.
13. Karlberg A.T., Dooms-Goossens A. Contact Dermatitis 1997, 36:201.
14. Liberato D.J., Byers V.S., Dennick R.G., Castagnoli N. J. Med. Chem. 1981, 24:28.
15. Skold M., Borje A., Matura M., Karlberg A.T. Contact Dermatitis 2002, 46:267.
16. Baron J.M., Holler D., Schiffer R., Frankenberg S., Neis M., Merk H.F., Jugert F.K. J. Invest. Dermatol. 2001, 116:541.
17. Saeki M., Saito Y., Nagano M., Teshima R., Ozawa S., Sawada J. Int. Arch. Allergy Immunol. 2002, 127:333.
18. Yengi L.G., Xiang Q., Pan J., Scatina J., Kao J., Ball S.E., Fruncillo R., Ferron G., Roland Wolf C. Anal. Biochem. 2003, 316:103.
19. Cheung C., Smith C.K., Hoog J.O., Hotchkiss S.A. Biochem. Biophys. Res. Commun. 1999, 261:100.
20. Janmohamed A., Dolphin C.T., Phillips I.R., Shephard E.A. Biochem. Pharmacol. 2001, 62:777.
21. Barratt M.D., Basketter D.A. Contact Dermatitis 1992, 27:98.
22. Bertrand F., Basketter D.A., Roberts D.W., Lepoittevin J.P. Chem. Res. Toxicol. 1997, 10:335.
23. Thompson D., Constantin-Teodosiu D., Egestad B., Mickos H., Moldeus P. Biochem. Pharmacol. 1990, 39:1587.
24. Baumann A., Faust A., Law M.P., Kuhlmann M.T., Kopka K., Schafers M., Karst U. Anal. Chem. 2011, 83:5415.
25. Baumann A., Lohmann W., Rose T., Ahn K.C., Hammock B.D., Karst U., Schebb N.H. Drug. Metab. Dispos. 2011, 38:2130.
26. Baumann A., Lohmann W., Schubert B., Oberacher H., Karst U. J. Chromatogr. A 2009, 1216:3192.
27. Jurva U., Wikstrom H.V., Bruins A.P. Rapid Commun. Mass. Spectrom. 2000, 14:529.
28. Lohmann W., Dötzer R., Gutter G., Van Leeuwen S.M., Karst U. J. Am. Soc. Mass Spectrom. 2009, 20:138.
29. Johansson T., Weidolf L., Jurva U. Rapid Commun. Mass Spectrom. 2007, 21:2323.
30. Lohmann W., Karst U. Anal. Bioanal. Chem. 2006, 386:1701.
31. Jurva U., Holmen A., Gronberg G., Masimirembwa C., Weidolf L. Chem. Res. Toxicol. 2008, 21:928.
32. Baumann A., Karst U. Expert Opin. Drug. Metab. Toxicol. 2010, 6:715.
33. Lohmann W., Karst U. Anal. Bioanal. Chem. 2008, 391:79.
34. Nouri-Nigjeh E., Bischoff R., Bruins A.P., Permentier H.P. Curr. Drug Metab. 2010, 12:359.
35. Permentier H.P., Bruins A.P., Bischoff R. Mini Rev. Med. Chem. 2008, 8:46.
36. Lohmann W., Hayen H., Karst U. Anal. Chem. 2008, 80:9714.